Jesse I. Treu, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 26,870 shares at $5.01 ($134K) on 2013-02-14, disclosed to the SEC on 2013-02-15.
Scheduled sale ($134k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 17,770 | $89K | 66.1% |
| 2 | $5.01 | 9,100 | $46K | 33.9% |
| Total | $5.00 avg | 26,870 | $134K | 100% |
| Filing → |
| OBLN | BUY | 2018-08-27 | $6.0M | — | Filing → |
| VCYT | SELL | 2018-08-02 | $10.8M | — | Filing → |
| VCYT | SELL | 2017-05-18 | $18K | — | Filing → |